Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Reply to Correspondence

Reply to correspondence on “Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: A multinational population-based cohort study from South Korea, Japan, and the UK”

Yang-Hyun Baek

Clin Mol Hepatol. 2025;31(1):e123-e124. Published online November 6, 2024

DOI: https://doi.org/10.3350/cmh.2024.0966

View: 310 Download: 10

Editorial

From past to pandemic: Health disparities in US hepatobiliary cancer mortality before and during COVID-19: Editorial on “Burden of mortality from hepatocellular carcinoma and biliary tract cancers by race and ethnicity and sex in US, 2018–2023”

Ilona Argirion

Clin Mol Hepatol. 2025;31(1):286-289. Published online August 5, 2024

DOI: https://doi.org/10.3350/cmh.2024.0597

View: 452 Download: 23

Original Article

Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: A multinational population-based cohort study from South Korea, Japan, and the UK

Kwanjoo Lee, Jaeyu Park, Jinseok Lee, Myeongcheol Lee, Hyeon Jin Kim, Yejun Son, Sang Youl Rhee, Lee Smith, Masoud Rahmati, Jiseung Kang, Hayeon Lee, Yeonjung Ha, Dong Keon Yon

Clin Mol Hepatol. 2024;30(4):943-958. Published online August 29, 2024

DOI: https://doi.org/10.3350/cmh.2024.0203

View: 2019 Download: 135 Web of Science: 3 Crossref: 2

Letter to the Editor

Correspondence on Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”

Ka Shing Cheung, Chiu Hang Mok, Wai Kay Seto, Man Fung Yuen

Clin Mol Hepatol. 2023;29(1):176-178. Published online November 10, 2022

DOI: https://doi.org/10.3350/cmh.2022.0377

View: 3252 Download: 54

Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”

Rujittika Mungmunpuntipantip, Viroj Wiwanitkit

Clin Mol Hepatol. 2023;29(1):168. Published online October 31, 2022

DOI: https://doi.org/10.3350/cmh.2022.0328

View: 3307 Download: 55 Web of Science: 1 Crossref: 1

Forms of cholangitis to be considered after SARS-CoV-2 infection

Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim

Clin Mol Hepatol. 2022;28(4):929-930. Published online September 8, 2022

DOI: https://doi.org/10.3350/cmh.2022.0260

View: 3011 Download: 64 Web of Science: 2 Crossref: 3

Autoimmune liver disease represented as primary biliary cholangitis after SARS-CoV-2 infection: A need for population-based cohort study

Soon Kyu Lee, Jung Hyun Kwon, Nara Yoon, Soon Woo Nam, Pil Soo Sung

Clin Mol Hepatol. 2022;28(4):926-928. Published online September 5, 2022

DOI: https://doi.org/10.3350/cmh.2022.0233

View: 3056 Download: 78 Web of Science: 2 Crossref: 3

Original Article

COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis

Ka Shing Cheung, Chiu Hang Mok, Xianhua Mao, Ruiqi Zhang, Ivan FN Hung, Wai Kay Seto, Man Fung Yuen

Clin Mol Hepatol. 2022;28(4):890-911. Published online June 3, 2022

DOI: https://doi.org/10.3350/cmh.2022.0087

View: 6079 Download: 189 Web of Science: 33 Crossref: 33

Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients

Ka Shing Cheung, Lok Ka Lam, Rex Wan Hin Hui, Xianhua Mao, Ruiqi R Zhang, Kwok Hung Chan, Ivan FN Hung, Wai Kay Seto, Man-Fung Yuen

Clin Mol Hepatol. 2022;28(3):553-564. Published online May 11, 2022

DOI: https://doi.org/10.3350/cmh.2022.0082

View: 4106 Download: 97 Web of Science: 13 Crossref: 14

Special Topic

Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline

Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim, on behalf of the Korean Association for the Study of the Liver

Clin Mol Hepatol. 2021;27(4):515-523. Published online September 17, 2021

DOI: https://doi.org/10.3350/cmh.2021.0293

View: 6515 Download: 90 Web of Science: 6 Crossref: 6

Original Article

Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea

Yu Rim Lee, Min Kyu Kang, Jeong Eun Song, Hyun Jung Kim, Young Oh Kweon, Won Young Tak, Se Young Jang, Jung Gil Park, Changhyeong Lee, Jae Seok Hwang, Byoung Kuk Jang, Jeong Ill Suh, Woo Jin Chung, Byung Seok Kim, Soo Young Park

Clin Mol Hepatol. 2020;26(4):562-576. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0126

View: 7398 Download: 187 Web of Science: 22 Crossref: 23

Special Topic

Management of liver diseases during the pandemic of coronavirus disease-19

Ju-Yeon Cho, Soon Sun Kim, Young-Sun Lee, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim, Korean Association for the Study of the Liver

Clin Mol Hepatol. 2020;26(3):243-250. Published online June 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0111

View: 7815 Download: 240 Web of Science: 8 Crossref: 7

1 |

Viewed By 6334	MAFLD: How is it different from NAFLD?
Viewed By 5378	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 5095	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4190	Examining the therapeutic landscape of beta-blockers in portal hypertension
Viewed By 3980	Gut microbiome and metabolome signatures in liver cirrhosis-related complications

Cited By 272	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 230	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 156	MAFLD: How is it different from NAFLD?
Cited By 79	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 76	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search